Expert-led guidance to strengthen diagnosis and treatment pathways in primary care.
Primary care physicians are increasingly on the front lines of managing complex chronic conditions, and hidradenitis suppurativa (HS) is a prime example of a disease demanding greater awareness and expertise. This often-misunderstood inflammatory skin condition, characterized by painful, recurring boil-like lumps, significantly impacts patients’ quality of life – extending beyond physical health to affect mental wellbeing, relationships, and financial stability. A new webinar, hosted by GHLF Australia and Hidradenitis Suppurativa Australia, aims to bridge the knowledge gap and improve patient outcomes.
- Addressing an Unmet Need: HS is frequently under-diagnosed and under-treated, leading to prolonged suffering for patients. This webinar directly tackles this issue.
- Multi-Disciplinary Approach: The session will cover diagnosis, treatment (including emerging therapies), and the crucial role of referral to dermatology, emphasizing a holistic patient management strategy.
- Patient Voice Included: Featuring a personal story from Steph Friend, founder of Hidradenitis Suppurativa Australia, the webinar will highlight the lived experience of HS, fostering empathy and understanding among healthcare providers.
The collaboration between GHLF Australia, a patient-centered organization focused on empowering individuals with chronic conditions, and Hidradenitis Suppurativa Australia underscores a growing trend: the vital partnership between patient advocacy groups and medical professionals. This webinar isn’t simply about disseminating information; it’s about amplifying the voices of those affected and driving improvements in care pathways. The increasing recognition of HS as a distinct and debilitating condition – moving beyond it being dismissed as a localized skin issue – is a key driver behind initiatives like this.
The webinar will delve into the core concepts of HS pathogenesis, providing GPs with a foundational understanding of the disease’s underlying mechanisms. Crucially, it will offer practical guidance on diagnostic criteria and disease staging, enabling earlier and more accurate diagnoses. The focus on a holistic approach – encompassing lifestyle modifications, medical therapies, and emerging treatments – reflects a shift towards patient-centered care that acknowledges the multifaceted impact of HS.
Looking Ahead: The success of this webinar will likely fuel demand for similar educational programs targeting other chronic inflammatory conditions often overlooked in primary care. We can anticipate a ripple effect, with increased awareness leading to earlier diagnoses, more effective treatment plans, and ultimately, a better quality of life for HS patients. Furthermore, the emphasis on referral to dermatology suggests a potential increase in specialist consultations, highlighting the need for improved coordination of care between primary and specialist providers. The inclusion of patient narratives, like Steph Friend’s, is a powerful tool that will likely be replicated in future educational initiatives, reinforcing the importance of empathy and patient-centeredness in healthcare.
DATE: Wednesday 11 March 2026
EVENT TIME: 7PM – 7.30 AEDT
LOCATION: Live on YouTube. Link provided through registration.
If you have any questions, please get in touch with Naomi Creek at GHLF Australia, [email protected]
ABOUT GHLF AUSTRALIA
GHLF Australia is a not-for-profit patient organisation whose mission is to empower Australians living with chronic conditions to put themselves at the centre of their care by talking about their treatment preferences and working in partnership with their healthcare providers.
ABOUT HIDRADENITIS SUPPURATIVA AUSTRALIA
Hidradenitis Suppurativa Australia is an Australian not-for-profit organisation dedicated to working together with medical professionals, patients, researchers and the wider community to improve the lives of those living with HS.
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.
